insulin glulisine vs pramlintide
Side-by-side comparison of insulin glulisine and pramlintide. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
moderate Known Drug Interaction
7 DRUG INTERACTIONS Table 6: Clinically Significant Drug Interactions with APIDRA Drugs that May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics.
Recommendation: Your doctor may need to adjust your insulin dose and you should check your blood sugar more often.
Apidra
Symlin
Apidra is a rapid-acting insulin that helps control blood sugar levels in people with diabetes. It works quickly to lower blood sugar after meals.
Symlin is a drug that helps control blood sugar in people with type 1 or type 2 diabetes who also use insulin. It works with insulin to lower blood sugar levels after meals.
Apidra is used to improve blood sugar control in adults and children with diabetes. Diabetes is a condition where your body does not make enough insulin or cannot use insulin properly, leading to high blood sugar levels. This medicine helps to lower your blood sugar levels.
Symlin is used to help manage blood sugar levels in adults with type 1 or type 2 diabetes. You should already be using insulin at mealtimes. This medicine is for people whose blood sugar is not well-controlled, even with the best insulin treatment.
Apidra is a type of insulin that works fast. It helps your body use sugar from the food you eat. This lowers the amount of sugar in your blood.
Symlin is similar to a natural hormone in your body. It slows down how quickly food leaves your stomach. It also helps to prevent your liver from releasing too much sugar after you eat, and reduces your appetite.
- • Upper respiratory infection
- • Nasopharyngitis (common cold)
- • Hypoglycemia (low blood sugar)
- • Edema peripheral (swelling in hands or feet)
- • Arthralgia (joint pain)
- • Nausea
- • Vomiting
- • Loss of appetite
- • Headache
- • Fatigue
- High blood sugar 1,527
- Low blood sugar 756
- High blood sugar 634
- Low blood sugar 445
- Feeling dizzy 401
- High blood sugar 15
- Sudden kidney damage 11
- Long-term kidney disease 11
- Feeling sick to your stomach 9
- Shortness of breath 8
Never share your Apidra SoloStar pen with anyone else, even if you change the needle. Sharing pens can spread blood-borne diseases. Changes in your insulin regimen should be made carefully under medical supervision because it can cause hyperglycemia or hypoglycemia. Low potassium levels in your blood can occur and may be life-threatening. Watch for signs of heart failure if you are also taking thiazolidinediones (TZDs).
Symlin can cause very low blood sugar, especially if you have type 1 diabetes. This can happen within 3 hours after a Symlin shot. To avoid this, follow your doctor's instructions carefully and check your blood sugar often. Make sure you know the signs of low blood sugar.
Tell your doctor if you are pregnant or plan to become pregnant. Poorly controlled diabetes during pregnancy can harm both the mother and the baby. Discuss the risks and benefits of using Apidra with your doctor if you are breastfeeding.
It is not known if Symlin will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if Symlin passes into breast milk, so discuss breastfeeding with your doctor.
Also Compare, Nearby Drugs
Compare insulin glulisine with
How to Read This insulin glulisine vs pramlintide Comparison
insulin glulisine is classified in the Rapid-Acting Insulin drug class, while pramlintide sits within the Amylin Analog class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, insulin glulisine has 3,763 submissions while pramlintide has 54. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to pramlintide can increase the risk of low blood sugar when taken with insulin.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between insulin glulisine and pramlintide - always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.